nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

31.01.2018 | Image of the Month

Glioblastoma multiforme: another potential application for ⁶⁸Ga-PSMA PET/CT as a guide for targeted therapy

verfasst von: Jolanta Kunikowska, Królicki Bartosz, Królicki Leszek

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Excerpt

…

Nomura N, Pastorino S, Jiang P, et al. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int. 2014;14:26.CrossRefPubMedPubMedCentral

Demirci E, Ocak M, Kabasakal L, et al. (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2014;41:1461–2.CrossRefPubMed

Sasikumar A, Joy A, Nanabala R, et al. 68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2016;43:795–6.CrossRefPubMed

Wernicke AG, Edgar MA, Lavi E, et al. Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme. Arch Pathol Lab Med. 2011;135:1486–9.CrossRefPubMed

Salas Fragomeni RA, Menke JR, Holdhoff M, et al. Prostate-specific membrane antigen-targeted imaging with [18F]DCFPyL in high-grade gliomas. Clin Nucl Med. 2017;42:e433–5.CrossRefPubMed

Titel: Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy
verfasst von: Jolanta Kunikowska
Królicki Bartosz
Królicki Leszek
Publikationsdatum: 31.01.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-3934-2

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis

Reply: Interim FDG-PET/CT in primary mediastinal diffuse large B-cell lymphoma: really almost useless procedure?

Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients

Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy

The diagnostic value of 18F–FDG-PET/CT and MRI in suspected vertebral osteomyelitis – a prospective study

Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer